Epigral Limited (NSE:EPIGRAL)

Market Cap	53.79B -36.1%
Revenue (ttm)	25.42B -0.3%
Net Income	3.32B -7.2%
EPS	76.95 -9.1%
Shares Out	43.14M
PE Ratio	16.20
Forward PE	13.29
Dividend	7.00 (0.54%)
Ex-Dividend Date	n/a

Volume	95,811
Average Volume	113,989
Open	1,299.30
Previous Close	1,300.50
Day's Range	1,218.70 - 1,304.00
52-Week Range	807.00 - 2,114.00
Beta	0.23
RSI	57.86
Earnings Date	May 2, 2026

About Epigral

Epigral Limited manufactures and sells chlor-alkali and related derivatives in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resins and compounds, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agroc...

• Industry: Chemicals
• Sector: Materials
• Founded: 2007
• Employees: 1,072
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: EPIGRAL

Financial Performance

In fiscal year 2026, Epigral's revenue was 25.42 billion, a decrease of -0.31% compared to the previous year's 25.50 billion. Earnings were 3.32 billion, a decrease of -7.19%.